Spanish Center's Early Experience With Donation Following Circulatory Death in Heart Transplantation

Jose María Arribas-Leal1, Antonio Jiménez-Aceituna1, Ramón Aranda-Domene1

  • 1From the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|May 16, 2025
PubMed

Insights

Heart transplantation using donation after circulatory death (DCD) grafts shows comparable hospital outcomes to donation after brain death (DBD) grafts. This approach may increase donor hearts without compromising early patient survival.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Surgical Innovation

Background:

  • Donation after circulatory death (DCD) heart transplantation is re-emerging as a strategy to increase donor organ availability.
  • While promising, the clinical outcomes of DCD heart transplants require thorough evaluation compared to traditional donation after brain death (DBD) methods.

Purpose of the Study:

  • To compare the clinical outcomes of heart transplantation using DCD versus DBD donors.
  • To assess the impact of DCD donation on graft availability and patient survival.

Main Methods:

  • A retrospective analysis of adult patients undergoing isolated heart transplantation between 2012 and 2023.
  • Comparison of patient demographics, pre-transplant characteristics, and early post-operative outcomes between DCD and DBD graft recipients.

Main Results:

  • DCD donors were more frequently local, and recipients required fewer ventricular assist devices and less urgent status.
  • DCD grafts experienced significantly shorter myocardial ischemia and extracorporeal circulation times.
  • No significant differences were observed in primary graft failure or hospital mortality between DCD and DBD groups.

Conclusions:

  • Cardiac transplantation using DCD donors yields hospital outcomes comparable to DBD donors.
  • Further long-term follow-up is essential to evaluate rejection, graft vascular disease, and overall mortality in DCD heart recipients.